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The histology of signet-ring cell carcinoma (SRC) of the stomach has been revisited with the support of current immuno-
histochemical techniques in order to explain particular features of this tumor; its great capacity of local diffusion and lymph 
node metastasis, also through a neo-lymphoangiogenesis. An observational retrospective study on 50 cases of SRC in stage 
II and III has been performed with the addition of histochemical (Alcian Blue, DDD-Fast Blue B, Mercury Orange) and 
immunohistochemical (cytocheratin, CD3, CD4, CD8, CD10, CD56, CD68, perforin, granzyme B, podoplanin, collagen 
type IV) investigations for each case. The signet ring cells, typical for this tumor, show abundant content of electro-negative 
sialomucins and demonstrate a great capacity of diffusion through the gastric wall. They evoke production and deposition 
of collagen type IV in the sub-mucosa layer through the local action of fibroblasts. The immunological response to this 
tumor in the gastric wall and in the metastatic lymph nodes is represented by an increase of B and T-helper lymphocytes, 
but not of T-killers or natural killers. The neoplastic cells are curiously able to avoid these newly formed ‘lymph nodules’. An 
extended neo-lymphangiogenesis has been observed around the primary tumor and in metastatic lymph nodes. A careful 
immunohistochemical characterization has allowed a better knowledge of SRC, regarding especially the peculiar behavior 
of local diffusion of its cells, the associated neo-lymph angiogenesis, and poor immunological reaction. 
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Stomach cancers are overwhelmingly composed of adeno-
carcinomas (90%), followed by lymphomas (5%), carcinoids 
and stromal tumors [1]. Histologically, according to the 
Lauren’s classification there are two major types of gastric 
adenocarcinomas: intestinal type or diffuse type. Intestinal 
type adenocarcinoma tends to form glandular structures 
with multiple lumens and reduced stroma with a ‘back-
to-back’ appearance. Often, it associates with intestinal 
metaplasia in neighboring mucosa. Depending on glandular 
architecture, cellular pleomorphism and muco-secretion, it 
can present three degrees of differentiation: well differenti-
ated (G1), moderate differentiated (G2) and poorly differ-
entiated/undifferentiated (G3) [1]. Diffuse type adenocar-
cinoma (linitis plastica, leather-bottle stomach) tumor cells 
are discohesive and secrete mucus, which can be delivered 
into the interstitium and produce large pools, or can remain 
inside the tumor cell, pushing the nucleus to the periphery in 
a ‘signet-ring’ fashion. By definition, diffuse type adenocarci-
noma is poorly differentiated/undifferentiated [1]. The great 
majority of gastric adenocarcinomas develops histologically 
differentiated tumors and a significant proportion of these 
progress until they become undifferentiated. However, a 
subset of gastric adenocarcinomas develops as undifferenti-
ated carcinomas, including signet-ring cell carcinoma (SRC) 
[1]. Our attention has been precisely focused on SRC for its 
particular histological features and clinical behavior. Today, 
the immunohistochemical techniques allow to better under-
stand local and distant diffusion. Cancer is in fact charac-
terized by some major hallmarks: sustaining proliferative 
signaling, evading growth suppressors, activating invasion 
and metastasis, enabling replicative immortality, inducing 
angiogenesis and resisting cell death [2]. From the beginning 
of XXI century, several evidences support the importance of 
immunity against cancer and, therefore, the ability to escape 
immune-mediated destruction was introduced as a further 
hallmark of cancer [3]. The most commonly used system 
for classifying the tumor extent and spread is TNM (Tumor 
Node Metastasis). However, it is well-known that the system 
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fails to consider the effects of host immune response against 
cancer cells and that clinical outcome can significantly vary 
among patients within the same TNM stage [4]. To overcome 
this limit, the concept of immunoscore was proposed, which 
incorporates immunity into tumor classification, improving 
the prognostic accuracy [5]. It is based on the evaluation and 
quantification of tumor-infiltrating lymphocytes and in situ 
immune response [6]. By exploiting specific immunohis-
tochemical antibodies, we have also investigated in SRC all 
of the main lymphocytic sub-populations, the related most 
common molecules of cytotoxicity, and the presence of histo-
cytes, fibroblasts and collagen type IV, and correlated them 
with the above-mentioned cancer hallmarks of lymphangio-
genesis and disruptive growth.
Patients and methods
Retrospectively, we have in-depth evaluated the histology 
of 50 SRC cases, 25 females and 25 males, aged between 
53 and 76 years, diagnosed from 2000 to 2010. All these 
patients were submitted to a curative subtotal distal gastrec-
tomy with D2-lymphadenectomy and the gastric tumor was 
confirmed to be SRC in stage II (27 cases) or III (23 cases). 
An unfavorable course of the neoplastic disease followed in 
all cases, with decease within 36 months. From a representa-
tive paraffin block of each neoplastic case, new tissue sections 
were obtained and submitted to histochemistry (Alcian Blue, 
DDD-Fast Blue B, Mercury Orange) and immunohisto-
chemical characterization. More in detail, after deparaffiniza-
tion, hydration, endogenous peroxidase blocking and heat-
induced antigen retrieval, the tissue sections were incubated 
for 30 minutes at room temperature with anti-cytokeratin 
(clone MNF116; Dako, Glostrup, Denmark), anti-CD3 
(clone 2GV6; Ventana, Tucson, AZ, USA), anti-CD4 (clone 
SP35; Ventana), anti-CD8 (clone SP57; Ventana), anti-CD10 
(clone SP67; Ventana), anti-CD56 (clone SP35; Ventana), 
anti-CD68 (clone KP1; Ventana), anti-perforin (clone 
MRQ-23; Ventana), anti-granzyme B (polyclonal; Ventana), 
anti-podoplanin (clone D2-40; Ventana), anti-collagen type 
IV (CIV22; Ventana). Biotinylated secondary antibody was 
applied and the staining product was detected with avidin-
biotin complex against a hematoxylin counterstain. Detec-
tion of the staining reaction was achieved by an enzyme 
conjugated polymer complex adapted for automatic stainers 
from Roche Ventana Medical Systems, with 3-3’ diamino-
benzidine tetrahydrochloride as chromogen.
Figure 1. Gastric signet-ring cell carcinoma characterized by the presence of classical signet-ring cells (A, H&E, 20×): inside and outside of the neoplas-
tic cells, accumulations of blue-stained sialomucins are observable (B, Alcian Blue, pH 2.5, 20×). Several histocytes are intermingled with the cancer 
cells (C, CD68, 50X), and a diffuse deposition of collagen type IV is noticeable (D, collagen type IV, 50×).
Figure 2. Numerous ‘lymph nodules’ in the submucosa of a stomach involved in signet-ring cell carcinoma (A, H&E, 5×); neoplastic cells, brown-
stained by anti-cytokeratin, escape the ‘lymph nodules’ (B, cytokeratin, 5×). They consist of B lymphocytes (C, CD20, 5×), T-helper lymphocytes (D, 
CD4, 5×) and only scant T-killer lymphocytes (E, CD8, 5×).
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Results
Inside the core of all primary tumors, only scanty 
CD68-positive macrophages (Figure 1) without neutro-
phils was observed. The apoptosis-derived fragments of 
neutrophil cells, usually present in other more differenti-
ated carcinomas were absent. Around the primitive tumors, 
a neo-lymphangiogenesis was observed, represented by fine 
lymphatic podoplanin-positive capillaries, provided with 
a single layer of endothelial cells devoid of valves or other 
structures. Deposits of neoplastic cells were found inside in 
all cases. Interesting was the behavior of the signet-ring cells, 
typical constituents of this cancer. The abundant content 
of sialomucins present inside their cytoplasm was demon-
strated by Alcian Blue staining (Figure 1). The accumula-
tion of glycoconjugates rich in sialyl groups was further 
confirmed by both DDD-Fast Blue B and Mercury Orange 
staining methods for thiols. These cells did not aggregate in 
glandular-like structures, neither in the primary tumor, nor 
in the metastatic lymph nodes. True budding of compact 
structures was therefore absent. On the contrary, in all the 
examined cases we observed a migration of these elements 
through the entire gastric wall in a procession-like fashion, 
coordinated to get away from the ‘lymph nodules’ in order 
to escape them. This surprising attitude was well highlighted 
by immunohistochemistry for cytokeratin (Figure 2). These 
nodules, containing different types of lymphocytes, were 
mainly situated in the gastric submucosa (Figure 2), but 
also in the muscularis and sub-serosa layer, where their 
number increased passing from stage II to stage III. They 
did not further evolve toward true lymph nodes, but origi-
nated active germinative follicles. The immunohistochemical 
characterization of the cell population demonstrated an 
increase of CD20-positive B lymphocytes and CD4-positive 
T-helper, but not of CD8-positive T-killer or CD56-positive 
natural (N) killer lymphocytes in all cases (Figure 2). 
Moreover, we noted the absence of perforin and granzyme 
B, molecules with a notorious cytotoxic activity. Besides, in 
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develops between SRC and the tissue immune-competent 
cells, and involves the ‘lymphatic nodules’, which show germi-
native centers, increase in number, and become present along 
the entire gastric wall, also where they are usually absent. Their 
immunological activation is expressed by newly produced 
B-lymphocytes and T-helper, but not T-killer or N-killer 
lymphocytes, which could express a cytotoxic action against 
the neoplastic cells. This correlates well with the absence of 
corresponding markers of cytotoxicity, such as perforin and 
granzyme B. We are prone to believe that this immunosup-
pressive activity is performed by SRC cells through the selec-
tive release of cytokines, which by a paracrine action inhibit 
the recruitment of T-killer or N-killer lymphocytes, poten-
tially active against the neoplastic elements [7]. This equally 
takes place in the lymphatic structures of the gastric wall 
and of the metastatic lymph nodes. Similarly, the numerous 
fibroblasts present in the sub-mucosa generate collagen IV, 
an extracellular component that does not seem to influence 
per se the diffusion of the neoplastic cells. However, the same 
the gastric sub-mucosa, we observed an increased number 
of CD10-positive fibroblasts, accompanied by an abundant 
deposition of collagen type IV in 100% of cases (Figure 1). 
The metastatic lymph nodes appeared located not following 
a continuous array, but scattered in the whole tributary zone. 
Inside of them we noticed the same cells, just ascertained in 
the ‘lymphatic nodules’. A neo-lymphangiogenesis, equiva-
lent to that of the primary tumor was associated in all cases 
(Figure 3). The lymph nodes not involved in metastasis showed 
a normal compartmentalization with a standard lympho-
cytic distribution in absence of neo-lymphangiogenesis.
Discussion
The abundant content of sialomucins inside the cytoplasm 
of the tumor cells gives them the typical signet-ring appear-
ance and determines a negative electric charge on their 
surface. This opposes their contiguous standing and genera-
tion of budding and gland-like structures [4]. A cross-talking 
Figure 3. Nodal metastasis from gastric signet-ring cell carcinoma (A, H&E, 5×); the neoplastic nests evoke a conspicuous neo-lymphangiogenesis, 
invading the newly formed lymphatic capillaries (B, podoplanin, 5×). The residual lymph node shows a prevalence of B (C, CD20, 5×) and T-helper (D, 
CD4, 5×) lymphocytes, with only scant T-killer lymphocytes (E, CD8, 5×).
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activated fibroblasts are considered as agents potentially 
favoring the growth and diffusion of the neoplastic cells 
[8–11]. The presence of macrophages inside the tumor and in 
the metastatic lymph nodes testifies their role in promoting 
the tumor growth and diffusion through a neo-lymphoangio-
genesis stimulated by the release of humoral vascular growth 
factors. The absence of any other type of inflammatory circu-
lating cells in the primary tumor or in the metastatic lymph 
nodes supports this interpretation, suggesting a particular 
nature and role of these macrophages [12–15]. The evident 
neo-lymphangiogenesis that accompanies the development 
of SRC, correlates with the great invasiveness of this cancer. 
It can be favored by various humoral factors released by 
different cellular components, directly or indirectly corre-
lated with the tumor growth. Here, paracrine action can be 
considered [16–21]. The methodology of our study is rather 
not complete. It would be interesting to research the same 
histological aspects in the hepatic or pulmonary metas-
tases from SRC, but the rapid and unfavorable course of 
the neoplastic disease made this impossible. We acknowl-
edge that our results could be better and more appropriately 
interpreted, if disposing of equivalent complete bio-humoral 
correlations. This could not be performed by our observa-
tional retrospective methodology.
Our observations confirm SRC as a highly malignant tumor 
with a great local invasiveness and power of metastasizing. It 
is not accompanied by an effective immunological response. 
The contemporary process of neo-lymphoangiogenesis repre-
sents a direct consequence [22–25]. We hope that in a near 
future, the classification and staging of each gastric tumor case 
will include its immunological characterization, a complete 
study of its lymphatic apparatus, and of the immune response 
[26–33]. Our research represents a first approach to this 
problem, even if limited to a single particular gastric cancer.
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